Skip to main content

Table 2 Demographic and clinical care factors associated with uptake of contraception among abortion clients (n = 29,056)

From: Does the type of abortion provider influence contraceptive uptake after abortion? An analysis of longitudinal data from 64 health facilities in Ghana

Variable

Received postabortion contraception n = 18,761 %

Did not receive postabortion contraception n = 10,295 %

Univariate Poisson regression RR (95 % CI)

P-value*

Facility-level

    

  Hospital

59.4

40.6

1

 

  Health center

82.9

17.1

1.39 (1.37, 1.42)

 

  Maternity home

90.9

9.1

1.53 (1.50, 1.56)

<0.001

Facility region

    

  Ashanti

66.2

33.9

1

 

  Eastern

80.2

19.8

1.21 (1.19, 1.24)

 

  Greater Accra

53.9

46.1

0.81 (0.80, 0.83)

<0.001

Type of provider

    

  House Officer

45.8

54.2

1

 

  Physician

53.2

46.8

1.16 (1.11, 1.21)

 

  Midwife

81.2

18.8

1.77 (1.70, 1.85)

<0.001

Client age

    

  10-19

72.9

27.1

1

 

  20-29

66.2

33.8

0.91 (0.89, 0.93)

 

  30-39

60.3

39.7

0.83 (0.81, 0.85)

 

  40-49

60.2

39.8

0.82 (0.78, 0.87)

<0.001

Trimester

    

  1st Tri

67.9

32.1

1

 

  2nd Tri

50.8

49.2

0.75 (0.72, 0.78)

<0.001

Procedure type

    

  MVA or EVA

63.9

36.1

1

 

  Medical abortionb

79.9

20.1

1.25 (1.21, 1.29)

 

  D&C or D&E

76.7

23.3

1.20 (1.08, 1.33)

<0.001

Indication for abortion

    

  Postabortion care

52.6

47.4

1

 

  Induced abortion

81.5

18.6

1.55 (1.52, 1.57)

<0.001

  1. RR, risk ratio; CI, confidence interval; MVA, manual vacuum aspiration; EVA, electric vacuum aspiration; D&C, dilation & curettage; D&E, dilation & extraction
  2. *P-value for the 2-tailed test of the null hypothesis that the regression coefficient is equal to zero
  3. bMedical abortion refers to treatment with either misoprostol or a combination misoprostol and mifepristone